SCHEMBL2700675

SCHEMBL2700675

Cc1cccc(CN(c2ccc(C#N)cc2)n2cnnc2)c1

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 20/20 0.74
STS P08842 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2703107 0.85 CYP19A1 (0.74) CYP19A1STS
SCHEMBL12189188 0.85 CYP19A1 (0.74) CYP19A1STS
SCHEMBL2060143 0.85 CYP19A1 (1.00) CYP19A1
SCHEMBL2702534 0.84 CYP19A1 (0.76) CYP19A1STS
SCHEMBL8446304 0.84 CYP19A1 (0.75) CYP19A1STS
SCHEMBL10062722 0.84 CYP19A1 (0.58) CYP19A1STS
SCHEMBL8446302 0.82 CYP19A1 (0.86) CYP19A1STS
SCHEMBL2060151 0.80 CYP19A1 (0.72) CYP19A1STS
SCHEMBL12171652 0.80 CYP19A1 (0.48) CYP19A1STS
SCHEMBL12171667 0.80 CYP19A1 (0.48) CYP19A1STS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2450354-B1 LABELING COMPOUND FOR PET RIKEN (JP) 2016-08-17 EP disclosed
EP-2450354-B1 LABELING COMPOUND FOR PET RIKEN (JP) 2016-08-17 EP disclosed
US-20120230914-A1 LABELING COMPOUND FOR PET RIKEN (JP) 2012-09-13 US disclosed
US-20120230914-A1 LABELING COMPOUND FOR PET RIKEN (JP) 2012-09-13 US disclosed
EP-2450354-A1 LABELING COMPOUND FOR PET Riken (JP) 2012-05-09 EP disclosed
EP-2450354-A1 LABELING COMPOUND FOR PET Riken (JP) 2012-05-09 EP disclosed
WO-2011002096-A1 LABELING COMPOUND FOR PET 独立行政法人理化学研究所 (JP) 2011-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120230914-A1 LABELING COMPOUND FOR PET CYP19A1, CYP2F1, CYP4F11 CYP19A1 1/4885STS 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.